706 First-in-human phase 2 clinical trial of multiplex combination intratumoral immunotherapy (MCII) in patients with metastatic solid cancer (Abscopal 5001 trial)
Auteurs principaux: | , , , , , , , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
BMJ Publishing Group
2023-11-01
|
Collection: | Journal for ImmunoTherapy of Cancer |